Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors

References

• Abraham KE, McMillen D, Brewer KL. 2004. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience. 124:945–952.
   PubMed Web of Science ®Google Scholar
• Austin PJ, Moalem-Taylor G. 2010. The neuroimmune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol. 229:26–50.
   PubMed Web of Science ®Google Scholar
• Bandow K, Kusuyama J, Shamoto M, Kakimoto K, Ohnishi T, Matsuguchi T. 2012. LPS-induced chemokine expression in both MyD88-dependent and -independent manners is regulated by Cot/Tpl2-ERK axis in macrophages. FEBS Lett. 586:1540–1546.
   PubMed Web of Science ®Google Scholar
• Bartel DL, Finger TE. 2013. Reactive microglia after taste nerve injury: comparison to nerve injury models of chronic pain. F1000Res 2. 65:1–13.
   Google Scholar
• Beggs S, Salter MW. 2013. The known knowns of microglia-neuronal signalling in neuropathic pain. Neurosci Lett. 557:37–42.
   PubMed Web of Science ®Google Scholar
• Bennett GJ, Xie Y-K. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87–107.
   PubMed Web of Science ®Google Scholar
• Bethea JR, Nagashima H, Acosta MC, Briceno C, Gomez F, Marcillo AE, Loor K, Green J, Dietrich WD. 1999. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma. 16:851–863.
   PubMed Web of Science ®Google Scholar
• Bettoni I, Comelli F, Rossini C, Granucci F, Giagnoni G, Peri F, Costa B. 2008. Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia. 56:1312–1319.
   PubMed Web of Science ®Google Scholar
• Bhangoo SK, Ren D, Miller RJ, Chan DM, Ripsch MS, Weiss C, McGinnis C, White FA. 2007. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav Immunity. 21:581–591.
   PubMed Web of Science ®Google Scholar
• Bishay P, Schmidt H, Marian C, Häussler A, Wijnvoord N, Ziebell S, Metzner J, Koch M, Myrczek T, Bechmann I, et al. 2010. R-Flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One. 5:e10628.
   PubMed Web of Science ®Google Scholar
• Brázda V, Klusáková I, Hradilová Svíženská I, Dubový P. 2013. Dynamic response to peripheral nerve injury detected by in situ hybridization of IL-6 and its receptor mRNAs in the dorsal root ganglia is not strictly correlated with signs of neuropathic pain. Mol Pain. 9:42.
   PubMed Web of Science ®Google Scholar
• Brewer KL, Bethea JR, Yezierski RP. 1999. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol. 159:484–493.
   PubMed Web of Science ®Google Scholar
• Calil IL, Zarpelon AC, Guerrero ATG, Alves-Filho JC, Ferreira SH, Cunha FQ, Cunha TM, Verri WA. 2014. Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw. PLoS One. 9:e90013.
   PubMed Web of Science ®Google Scholar
• Carrascal MT, Mendoza L, Valcárcel M, Salado C, Egilegor E, Tellería N, Vidal-Vanaclocha F, Dinarello CA. 2003. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res. 63:491–497.
   PubMed Web of Science ®Google Scholar
• Chen G, Park CK, Xie RG, Berta T, Nedergaard M, Ji RR. 2014. Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice. Brain*: J Neurol. 137:2193–2209.
   PubMed Web of Science ®Google Scholar
• Christianson CA, Dumlao DS, Stokes JA, Dennis EA, Svensson CI, Corr M, Yaksh TL. 2011. Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis. Pain. 152:2881–2891.
   PubMed Web of Science ®Google Scholar
• Colburn RW, Rickman AJ, DeLeo JA. 1999. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol. 157:289–304.
   PubMed Web of Science ®Google Scholar
• Cui Y, Liao XX, Liu W, Guo R-X, Wu Z-Z, Zhao C-M, Chen P-X, Feng J-Q. 2008. A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immunity. 22:114–123.
   PubMed Web of Science ®Google Scholar
• DeLeo J, Colburn R, Nichols M, Malhotra A. 1996. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interf Cytokine Res. 16:695–700.
   PubMed Web of Science ®Google Scholar
• DeLeo JA, Yezierski RP. 2001. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 90:1–6.
   PubMed Web of Science ®Google Scholar
• del Rey A, Yau H-J, Randolf A, Centeno MV, Wildmann J, Martina M, Besedovsky HO, Apkarian AV. 2011. Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts cytokine interactions in the hippocampus. Pain. 152:2827–2835.
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Fantuzzi G. 2003. Interleukin-18 and host defense against infection. J Infect Dis. 187:370–384.
   PubMed Web of Science ®Google Scholar
• Dubový P, Brázda V, Klusáková I, Hradilová-Svíženská I. 2013. Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve. J Neuroinflammation. 1055:1–22.
   Google Scholar
• Flatters SJL, Fox AJ, Dickenson AH. 2003. Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res. 984:54–62.
   PubMed Web of Science ®Google Scholar
• Gallo A, Dimiziani A, Damblon J, Michot B, Rieux A, De Kock M, Hermans E, Deumens R. 2015. Modulation of spinal glial reactivity by intrathecal PPF is not sufficient to inhibit mechanical allodynia induced by nerve crush. Neurosci Res. 95:78–82.
   PubMed Web of Science ®Google Scholar
• Ghasemzadeh MR, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. 2016. Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. J Ethnopharmacol. 194:117–130.
   PubMed Web of Science ®Google Scholar
• Gruol DL, Nelson TE. 1997. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol. 15:307–339.
   PubMed Web of Science ®Google Scholar
• Guerrero ATG, Pinto LG, Cunha FQ, Ferreira SH, Alves-Filho JC, Verri WA, Cunha TM. 2016. Mechanisms underlying the hyperalgesic responses triggered by joint activation of TLR4. Pharmacol Rep. 68:1293–1300.
   PubMed Web of Science ®Google Scholar
• Hains BC, Waxman SG. 2006. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci: Off J Soc Neurosci. 26:4308–4317.
   PubMed Web of Science ®Google Scholar
• Henry MA, Fairchild DD, Patil MJ, Hanania T, Hain HS, Davis SF, Malekiani SA, Hu A, Sucholeiki R, Nix D, et al. 2015. Effect of a novel, orally active matrix metalloproteinase-2 and -9 inhibitor in spinal and trigeminal rat models of neuropathic pain. J Oral Facial Pain Headacheoral Pain. 29:286–296.
   PubMed Web of Science ®Google Scholar
• Holm TH, Draeby D, Owens T. 2012. Microglia are required for astroglial toll-like receptor 4 response and for optimal TLR2 and TLR3 response. Glia. 60:630–638.
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Northcutt AL, Chao LW, Kearney JJ, Zhang Y, Berkelhammer DL, Loram LC, Rozeske RR, Bland ST, Maier SF, et al. 2008. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav Immunity. 22:1248–1256.
   PubMed Web of Science ®Google Scholar
• Inoue K. 2006. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Therapeutics. 109:210–226.
   PubMed Web of Science ®Google Scholar
• Jiang BC, Cao DL, Zhang X, Zhang ZJ, He LN, Li CH, Zhang WW, Wu XB, Berta T, Ji RR, et al. 2016. CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5. J Clin Invest. 126:745–761.
   PubMed Web of Science ®Google Scholar
• Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J. 2017. Blockade of P2X4 receptors inhibits neuropathic pain-related behavior by preventing MMP-9 activation and, consequently, pronociceptive interleukin release in a rat model. Front Pharmacol. 8:1–18.
   PubMed Web of Science ®Google Scholar
• Jurga AM, Piotrowska A, Starnowska J, Rojewska E, Makuch W, Mika J. 2016. Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats. Pharmacol Rep. 68:206–213.
   PubMed Web of Science ®Google Scholar
• Jurga AM, Rojewska E, Piotrowska A, Makuch W, Pilat D, Przewlocka B, Mika J. 2016. Blockade of toll-like receptors (TLR2, TLR4) attenuates pain and potentiates buprenorphine analgesia in a rat neuropathic pain model. Neural Plast. 2016:5238730.
   PubMed Web of Science ®Google Scholar
• Kang SY, Roh DH, Choi JW, Ryu Y, Lee JH. 2015. Repetitive treatment with diluted bee venom attenuates the induction of below-level neuropathic pain behaviors in a rat spinal cord injury model. Toxins (Basel). 7:2571–2585.
   PubMed Web of Science ®Google Scholar
• Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, Gao YJ, Roy K, Corfas G, Lo EH, et al. 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med. 14:331–336.
   PubMed Web of Science ®Google Scholar
• Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. 2000. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA. 97:1190–1195.
   PubMed Web of Science ®Google Scholar
• Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312–318.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Jurga A, Slusarczyk J, Trojan E, Basta-Kaim A, Mika J. 2016. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats. Progress Neuro-Psychopharmacol Biol Psychiatry. 64:68–78.
   PubMed Web of Science ®Google Scholar
• Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan ED, Martin D, Maier SF, Johnson KW, Leinwand LA, et al. 2007. Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immunity. 21:686–698.
   PubMed Web of Science ®Google Scholar
• Leduc-Pessah H, Weilinger NL, Fan CY, Burma NE, Thompson RJ, Trang T. 2017. Site-specific regulation of P2X7 receptor function in microglia gates morphine analgesic tolerance. J Neurosci: Off J Soc Neurosci. 37:10154–10172.
   PubMed Web of Science ®Google Scholar
• Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. 2003. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA. 100:8514–8519.
   PubMed Web of Science ®Google Scholar
• Lewis SS, Hutchinson MR, Zhang Y, Hund DK, Maier SF, Rice KC, Watkins LR. 2013. Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain. Brain Behav Immunity. 30:24–32.
   PubMed Web of Science ®Google Scholar
• Li SS, Zhang WS, Ji D, Zhou YL, Li H, Yang JL, Xiong YC, Zhang YQ, Xu H. 2014. Involvement of spinal microglia and interleukin-18 in the anti-nociceptive effect of dexmedetomidine in rats subjected to CCI. Neurosci Lett. 560:21–25.
   PubMed Web of Science ®Google Scholar
• Li X, Wang XW, Feng XM, Zhou WJ, Wang YQ, Mao-Ying QL. 2013. Stage-dependent anti-allodynic effects of intrathecal Toll-like receptor 4 antagonists in a rat model of cancer induced bone pain. J Physiol Sci. 63:203–209.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang H, Zhang H, Kosturakis AK, Jawad AB, Dougherty PM. 2014. Toll-like receptor 4 signaling contributes to paclitaxel-induced peripheral neuropathy. J Pain. 15:712–725.
   PubMed Web of Science ®Google Scholar
• Liu F, Wang Z, Qiu Y, Wei M, Li C, Xie Y, Shen L, Huang Y, Ma C. 2017. Suppression of MyD88-dependent signaling alleviates neuropathic pain induced by peripheral nerve injury in the rat. J Neuroinflammation. 14:70.
   PubMed Web of Science ®Google Scholar
• Liu T, Gao YJ, Ji RR. 2012. Emerging role of toll-like receptors in the control of pain and itch. Neurosci Bull. 28:131–144.
   PubMed Web of Science ®Google Scholar
• Makuch W, Mika J, Rojewska E, Zychowska M, Przewlocka B. 2013. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Neuropharmacology. 75:445–457.
   PubMed Web of Science ®Google Scholar
• Malcangio M, Bowery N, Flower R, Perretti M. 1996. Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. Eur J Pharmacol. 299:113–118.
   PubMed Web of Science ®Google Scholar
• Marchand F, Perretti M, McMahon SB. 2005. Role of the immune system in chronic pain. Nature reviews. Neuroscience. 6:521–532.
   PubMed Web of Science ®Google Scholar
• Mika J. 2008. Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol Rep. 60:297–307.
   PubMed Web of Science ®Google Scholar
• Mika J, Korostynski M, Kaminska D, Wawrzczak-Bargiela A, Osikowicz M, Makuch W, Przewlocki R, Przewlocka B. 2008. Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain. 138:587–597.
   PubMed Web of Science ®Google Scholar
• Mika J, Osikowicz M, Makuch W, Przewlocka B. 2007. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol. 560:142–149.
   PubMed Web of Science ®Google Scholar
• Mika J, Osikowicz M, Rojewska E, Korostynski M, Wawrzczak-Bargiela A, Przewlocki R, Przewlocka B. 2009. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol. 623:65–72.
   PubMed Web of Science ®Google Scholar
• Mika J, Rojewska E, Makuch W, Przewlocka B. 2010. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience. 165:1420–1428.
   PubMed Web of Science ®Google Scholar
• Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. 2013. Importance of glial activation in neuropathic pain. Eur J Pharmacol. 716:106–119.
   PubMed Web of Science ®Google Scholar
• Milligan ED, Penzkover KR, Soderquist RG, Mahoney MJ. 2012. Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation Technol Neural Interface. 15:520–526.
   PubMed Web of Science ®Google Scholar
• Milligan ED, Soderquist RG, Malone SM, Mahoney JH, Hughes TS, Langer SJ, Sloane EM, Maier SF, Leinwand LA, Watkins LR, et al. 2006. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol. 2:293–308.
   PubMed Web of Science ®Google Scholar
• Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. 2008. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci: Off J Soc Neurosci. 28:12775–12787.
   PubMed Web of Science ®Google Scholar
• Moore KW, O’Garra A, Malefyt RW, Vieira P, Mosmann TR. 1993. Interleukin-10. Annu Rev Immunol. 11:165–190.
   PubMed Web of Science ®Google Scholar
• Murphy PG, Borthwick LA, Altares M, Gauldie J, Kaplan D, Richardson PM. 2000. Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons. Eur J Neurosci. 12:1891–1899.
   PubMed Web of Science ®Google Scholar
• Oprée A, Kress M. 2000. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci. 20:6289–6293.
   PubMed Web of Science ®Google Scholar
• Penkowa M, Giralt M, Lago N, Camats J, Carrasco J, Hernández J, Molinero A, Campbell IL, Hidalgo J. 2003. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp Neurol. 181:130–148.
   PubMed Web of Science ®Google Scholar
• Perry VH, Teeling J. 2013. Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration. Semin Immunopathol. 35:601–612.
   PubMed Web of Science ®Google Scholar
• Pilat D, Piotrowska A, Rojewska E, Jurga A, Slusarczyk J, Makuch W, Basta-Kaim A, Przewlocka B, Mika J. 2016. Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine. Mol Cell Neurosci. 71:114–124.
   PubMed Web of Science ®Google Scholar
• Pilat D, Rojewska E, Jurga AM, Piotrowska A, Makuch W, Przewlocka B, Mika J. 2015. IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model. Eur J Pharmacol. 764:240–248.
   PubMed Web of Science ®Google Scholar
• Piotrowska A, Kwiatkowski K, Rojewska E, Slusarczyk J, Makuch W, Basta-Kaim A, Przewlocka B, Mika J. 2016. Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain – in vivo and in vitro evidence. J Neuroimmunol. 297:9–19.
   PubMed Web of Science ®Google Scholar
• Plater-Zyberk C, Joosten LA, Helsen MM, Sattonnet-Roche P, Siegfried C, Alouani S, van De Loo FA, Graber P, Aloni S, Cirillo R, et al. 2001. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest. 108:1825–1832.
   PubMed Web of Science ®Google Scholar
• Plunkett JA, Yu CG, Easton JM, Bethea JR, Yezierski RP. 2001. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol. 168:144–154.
   PubMed Web of Science ®Google Scholar
• Popiolek-Barczyk K, Kolosowska N, Piotrowska A, Makuch W, Rojewska E, Jurga AM, Pilat D, Mika J. 2015. Parthenolide relieves pain and promotes M2 microglia/macrophage polarization in rat model of neuropathy. Neural Plasticity. 2015:676473.
   PubMed Web of Science ®Google Scholar
• Popiolek-Barczyk K, Piotrowska A, Makuch W, Mika J. 2017. Biphalin, a dimeric enkephalin, alleviates lps-induced activation in rat primary microglial cultures in opioid receptor-dependent and receptor-independent manners. Neural Plasticity. 2017:3829472.
   PubMed Web of Science ®Google Scholar
• Qian B, Li F, Zhao LX, Dong YL, Gao YJ, Zhang ZJ. 2016. Ligustilide ameliorates inflammatory pain and inhibits TLR4 upregulation in spinal astrocytes following Complete Freund's Adjuvant Peripheral Injection. Cell Mol Neurobiol. 36:143–149.
   PubMed Web of Science ®Google Scholar
• Rojewska E, Korostynski M, Przewlocki R, Przewlocka B, Mika J. 2014. Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain. Mol Pain. 47:1–15.
   Google Scholar
• Rojewska E, Piotrowska A, Makuch W, Przewlocka B, Mika J. 2016. Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model. Neuropharmacology. 102:80–91.
   PubMed Web of Science ®Google Scholar
• Rojewska E, Popiolek-Barczyk K, Jurga AM, Makuch W, Przewlocka B, Mika J. 2014. Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model. J Neuroimmunol. 277:57–66.
   PubMed Web of Science ®Google Scholar
• Rojewska E, Popiolek-Barczyk K, Kolosowska N, Piotrowska A, Zychowska M, Makuch W, Przewlocka B, Mika J. 2015. PD98059 influences immune factors and enhances opioid analgesia in model of neuropathy. PLoS One. 10:1–19.
   Web of Science ®Google Scholar
• Sawada M, Suzumura A, Hosoya H, Marunouchi T, Nagatsu T. 1999. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia. J Neurochem. 72:1466–1471.
   PubMed Web of Science ®Google Scholar
• Swartz KR, Liu F, Sewell D, Schochet T, Campbell I, Sandor M, Fabry Z. 2001. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896:86–95.
   PubMed Web of Science ®Google Scholar
• Sweitzer S, Martin D, De Leo J. 2001. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience. 103:529–539.
   PubMed Web of Science ®Google Scholar
• Tanga F, Raghavendra V, De Leo J. 2004. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int. 45:397–407.
   PubMed Web of Science ®Google Scholar
• Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. 2001. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci: Off J Soc Neurosci. 21:2580–2588.
   PubMed Web of Science ®Google Scholar
• Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. 2004. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia. 45:89–95.
   PubMed Web of Science ®Google Scholar
• Vega-Avelaira D, Moss A, Fitzgerald M. 2007. Age-related changes in the spinal cord microglial and astrocytic response profile to nerve injury. Brain Behav Immunity. 21:617–623.
   PubMed Web of Science ®Google Scholar
• Verri WA, Cunha TM, Parada CA, Poole S, Liew FY, Ferreira SH, Cunha FQ. 2007. Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immunity. 21:535–543.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan X, Tang T, Fan R, Zhang C, Huang Z, Peng W, Gan P, Xiong X, Huang W, et al. 2016. Rhein and rhubarb similarly protect the blood-brain barrier after experimental traumatic brain injury via gp91phoxsubunit of NADPH oxidase/ROS/ERK/MMP-9 signaling pathway. Sci Rep. 6:37098.
   PubMed Web of Science ®Google Scholar
• Xu M, Bruchas MR, Ippolito DL, Gendron L, Chavkin C. 2007. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase. J Neurosci: Off J Soc Neurosci. 27:2570–2581.
   PubMed Web of Science ®Google Scholar
• Xu YQ, Jin SJ, Liu N, Li YX, Zheng J, Ma L, Du J, Zhou R, Zhao CJ, Niu Y, et al. 2014. Aloperine attenuated neuropathic pain induced by chronic constriction injury via anti-oxidation activity and suppression of the nuclear factor kappa B pathway. Biochem Biophys Res Commun. 451:568–573.
   PubMed Web of Science ®Google Scholar
• Yaksh T, Rudy T. 1976. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1031–1036.
   PubMed Web of Science ®Google Scholar
• Yao J, Keri JE, Taffs RE, Colton CA. 1992. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591:88–93.
   PubMed Web of Science ®Google Scholar
• Yu CG, Fairbanks CA, Wilcox GL, Yezierski RP. 2003. Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats. J Pain: Off J Am Pain Soc. 4:129–140.
   PubMed Web of Science ®Google Scholar
• Yu LN, Zhou XL, Yu J, Huang H, Jiang LS, Zhang FJ, Cao JL, Yan M. 2012. PI3K contributed to modulation of spinal nociceptive information related to ephrinBs/EPHBS. PLoS One. 7. 2012;7:e40930.
   PubMed Web of Science ®Google Scholar
• Zhang FF, Morioka N, Harano S, Nakamura Y, Liu K, Nishibori M, Hisaoka-Nakashima K, Nakata Y. 2016. Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloprotease-9 up-regulation in mice with painful peripheral neuropathy. J Neurochem. 136:837–850.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng W, Ao X, Dai H, Yuan L, Huang X, Zhou Q. 2015. TAK-242, a Toll-Like Receptor 4 antagonist, protects against aldosterone-induced cardiac and renal injury. PLoS One. 10:e0142456.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xin Y, Gao J, Teng R-Y, Chu H-C. 2015. Analgesic effect of TAK-242 on neuropathic pain in rats. Int J Clin Exp Med. 8:11202–11207.
   PubMed Web of Science ®Google Scholar
• Zhou TT, Wu JR, Chen ZY, Liu ZX, Miao B. 2014. Effects of dexmedetomidine on P2X4Rs, p38-MAPK and BDNF in spinal microglia in rats with spared nerve injury. Brain Res. 1568:21–30.
   PubMed Web of Science ®Google Scholar
• Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:109–110.
   PubMed Web of Science ®Google Scholar